• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDIVANCE, INC. ¿ 1725056 ARCTICGEL PADS; ARCTIC SUN GEL PADS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDIVANCE, INC. ¿ 1725056 ARCTICGEL PADS; ARCTIC SUN GEL PADS Back to Search Results
Catalog Number UNKNOWN
Device Problems Air Leak (1008); Inaccurate Flow Rate (1249); Device Displays Incorrect Message (2591)
Patient Problem No Code Available (3191)
Event Type  malfunction  
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.The device was not returned.
 
Event Description
It was reported that while cooling the patient, the device began giving a low air leak message under the flow rate.System diagnostics showed that the flow rate was 0lpm, ip was -0.1psi.And circulation pump demand was 100%.The nurse disconnected and reconnected the pads and the issue was not resolved.Therapy was interrupted in order to put the patient onto a second device.The target temperature was 36c , the patient's temperature was 35.1c, and the water temperature was 26.1c.The nurse stated that when they put the patient onto the second device the pads were not emptied.She was instructed to drain water from the circulation tank.The device began giving an alert 01.The flow rate was suboptimal and fluctuating between 1.2lpm and 1.5lpm.System diagnostics were checked showing that the flow rate was 0lpm, ip was -0.8psi, and the circulation pump was 100%.The pads were emptied and the water reservoir showed 4 bars.The nurse disconnected and reconnected the pad one at a time and the ip remained between -1.7psi and -2.9psi.The device was placed into manual mode with only the fluid delivery line attached.The flow rate was 1.8lpm, ip was -7.0psi, and the circulation pump demand was 49%.The right thigh pad was connected and the ip was -4psi.She disconnected the right thigh pad and connected the right chest pad and the ip was -2psi.The patient was (b)(6) with an exposed abdomen.Therapy was interrupted in order to replace the pads with a new set of pads.The patient's temperature was 34.4c, the water temperature was 40c and the flow rate was optimal at 2.8lpm with the new set of pads.
 
Manufacturer Narrative
The device was not returned for evaluation.The lot number is unknown; therefore, the device history record could not be reviewed.The instructions for use state the following: "indications for use: the arctic sun¿ temperature management system is intended for monitoring and controlling patient temperature.Contraindications: there are no known contraindications for the use of a thermoregulatory system.Do not place arcticgel" pads on skin that has signs of ulcerations, burns, hives or rash.While there are no known allergies to hydrogel materials, caution should be exercised with any patient with a history of skin allergies or sensitivities.Warning: do not place arcticgel" pads over transdermal medication patches as warming can increase drug delivery, resulting in possible harm to the patient.Cautions: federal law restricts this device to sale by or on the order of a physician.This product is to be used by or under the supervision of trained, qualified medical personnel.The clinician is responsible for determining the appropriateness of use of this device and the usersettable parameters, including water temperature, for each patient.For small patients (=30 kg) it is recommended to use the following settings: water temperature high limit =40¿c (104¿f); water temperature low limit =10¿c (64.4¿f); control strategy =2.It is recommended to use the patient temperature high and patient temperature low alert settings.Due to underlying medical or physiological conditions, some patients are more susceptible to skin damage from pressure and heat or cold.Patients at risk include those with poor tissue perfusion or poor skin integrity due to diabetes, peripheral vascular disease, poor nutritional status or steroid or high dose vasopressor therapy.If accessible, examine the patients skin under the arcticgel" pads often; especially those patients at higher risk of skin injury.Skin injury may occur as a cumulative result of pressure, time and temperature.Do not place bean bags or other firm positioning devices under the arcticgel" pads.Do not place any positioning devices under the pad manifolds or patient lines.Do not allow urine, antibacterial solutions or other agents to pool underneath the arcticgel" pads.Urine and antibacterial agents can absorb into the pad hydrogel and cause chemical injury and loss of pad adhesion.Replace pads immediately if these fluids come into contact with the hydrogel.Do not place arcticgel" pads directly over an electrosurgical grounding pad.The combination of heat sources may result in skin burns.Carefully remove arcticgel" pads from the patients skin at the completion of use.Aggressive removal or removal of cold pads from the patients skin may result in skin tears.The arcticgel" pads are non-sterile for single patient use only.Do not place pads in the sterile field.If used in a sterile environment, pads should be placed according to the physicians directions, either prior to the sterile preparation or sterile draping.Do not reprocess or sterilize.Use pads immediately after opening.Do not store pads in opened pouch.Do not allow circulating water to contaminate the field when lines are disconnected.The arcticgel" pads should not be punctured with sharp objects.Punctures will result in air entering the fluid pathway and may reduce performance.If warranted, use pressure relieving or pressure reducing devices under the patient to protect from skin injury.The arcticgel" pads are only for use with an arctic sun¿ temperature management system.The water content of the hydrogel affects the pads adhesion to the skin and conductivity, and therefore, the efficiency of controlling patient temperature.Periodically check that pads remain moist and adherent.Replace pads when the hydrogel no longer uniformly adheres to the skin.Replacing pads at least every 5 days is recommended.If needed, place defibrillation pads between the arcticgel" pads and the patients skin.Discard used arcticgel" pads in accordance with hospital procedures for medical waste.Directions for use: arcticgel" pads are only for use with an arctic sun¿ temperature management system control module.See operators manual for detailed instructions on system use.Select the proper number, size and style pad for the patient size and clinical indication.However, the rate of temperature change and potentially the final achievable temperature is affected by pad surface area, patient size, pad placement and water temperature range.Best system performance will be achieved by using the maximum number and largest size pads.For patient comfort, the pads may be prewarmed using water temperature control mode (manual) prior to application.Place the pads on healthy, clean skin only.Remove any creams or lotions from patients skin before pad application.Remove the release liner from each pad and apply to the appropriate area.The pads may be overlapped or folded adhesive-to-adhesive to achieve proper placement.The pads may be removed and reapplied if necessary.The pad surface must be contacting the skin for optimal energy transfer efficiency.Place pads to allow for full respiratory excursion.Attach the pads line connectors to the patient line manifolds.Begin circulating water through the pads using either patient temperature control mode (automatic) or water temperature control mode (manual).If the pads fail to prime or a significant continuous air leak is observed in the pad return line, check connections, then if needed replace the leaking pad.Once the pads are primed, assure the flow rate displayed on the control panel is greater than 2.3 liters per minute, which is the minimum flow rate for a full pad kit.When finished, empty water from pads.Cold temperature increases the adhesiveness of the hydrogel.For ease of removal, leave pads on the patient for approximately 15 minutes to allow the hydrogel to warm.Slowly remove pads from the patient and discard." (b)(4).
 
Event Description
It was reported that while cooling the patient, the device began giving a low air leak message under the flow rate.System diagnostics showed that the flow rate was 0lpm, inlet pressure (ip) was -0.1psi.And circulation pump demand was 100%.The nurse disconnected and reconnected the pads and the issue was not resolved.Therapy was interrupted in order to put the patient onto a second device.The target temperature was 36c, the patient's temperature was 35.1c, and the water temperature was 26.1c.The nurse stated that when they put the patient onto the second device the pads were not emptied.She was instructed to drain water from the circulation tank.The device began giving an alert 01.The flow rate was suboptimal and fluctuating between 1.2 liters/min (lpm) and 1.5 lpm.System diagnostics were checked showing that the flow rate was 0lpm, ip was -0.8psi, and the circulation pump was 100%.The pads were emptied and the water reservoir showed 4 bars.The nurse disconnected and reconnected the pad one at a time and the ip remained between -1.7psi and -2.9psi.The device was placed into manual mode with only the fluid delivery line attached.The flow rate was 1.8lpm, ip was -7.0psi, and the circulation pump demand was 49%.The right thigh pad was connected and the ip was -4psi.She disconnected the right thigh pad and connected the right chest pad and the ip was -2psi.The patient was 97kgs with an exposed abdomen.Therapy was interrupted in order to replace the pads with a new set of pads.The patient's temperature was 34.4c, the water temperature was 40c and the flow rate was optimal at 2.8lpm with the new set of pads.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCTICGEL PADS
Type of Device
ARCTIC SUN GEL PADS
Manufacturer (Section D)
MEDIVANCE, INC. ¿ 1725056
321 s taylor ave
louisville CO 80027
Manufacturer (Section G)
MEDIVANCE, INC. ¿ 1725056
321 s taylor ave
louisville CO 80027
Manufacturer Contact
amy gravley
8195 industrial blvd
covington, GA 30014
7707846100
MDR Report Key7038920
MDR Text Key93170945
Report Number1018233-2017-05948
Device Sequence Number1
Product Code DWJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K142702
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other,use
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 11/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/16/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/20/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Weight97
-
-